Lenvatinib 4mg Capsule

Lenvatinib 4 mg Tablet is a prescription tyrosine kinase inhibitor (TKI) used in the treatment of certain thyroid cancers, hepatocellular carcinoma (liver cancer), advanced renal cell carcinoma, and selected endometrial cancers in appropriate treatment regimens. Generic equivalent of Lenvima® 4 mg (Eisai) and widely prescribed worldwide as targeted cancer therapy. Buy from a trusted supplier with worldwide shipping where permitted.

Product Information

Generic Name

Lenvatinib 4 mg

Drug Class

Tyrosine Kinase Inhibitor (TKI); Multi-Kinase Inhibitor

Brand Reference

Lenvima® (Eisai)

Indication

Differentiated Thyroid Cancer (DTC), Hepatocellular Carcinoma (HCC), Advanced Renal Cell Carcinoma (RCC), and selected Endometrial Cancer treatment regimens

Form

Oral Capsule/Tablet*

Strength

4 mg

Packing

30 Tablets per Box

Route

Oral

Prescription

Yes

Evidence

FDA-approved; EMA-approved; NICE-recommended indications apply where appropriate

Availability & Ordering

Patients and healthcare professionals searching for Lenvatinib 4 mg Tablet, Buy Lenvatinib Online, Generic Lenvima® 4 mg, Lenvatinib Price USA UK, Targeted Cancer Therapy, and Tyrosine Kinase Inhibitor Tablets will find genuine stock available for worldwide shipping where permitted by local import regulations. All orders are securely dispatched. Prescription medicines should only be used under the supervision of a qualified healthcare professional.

How it works

Lenvatinib works by blocking multiple tyrosine kinase receptors involved in tumor growth and angiogenesis, including VEGF receptors. By inhibiting these pathways, Lenvatinib helps slow cancer cell growth and reduce the formation of blood vessels that supply tumors. It is widely used as targeted therapy for selected cancers and may be prescribed alone or in combination with other treatments under specialist supervision.